Hendershot Investments Inc. Purchases 1,228 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hendershot Investments Inc. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 41,260 shares of the healthcare conglomerate’s stock after acquiring an additional 1,228 shares during the quarter. UnitedHealth Group makes up about 3.0% of Hendershot Investments Inc.’s investment portfolio, making the stock its 9th biggest position. Hendershot Investments Inc.’s holdings in UnitedHealth Group were worth $21,012,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. International Assets Investment Management LLC grew its stake in UnitedHealth Group by 1.9% during the 4th quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock worth $2,352,000 after buying an additional 85 shares during the last quarter. Aveo Capital Partners LLC grew its stake in UnitedHealth Group by 23.8% during the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock worth $1,139,000 after buying an additional 416 shares during the last quarter. 9258 Wealth Management LLC grew its stake in UnitedHealth Group by 7.3% during the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after buying an additional 290 shares during the last quarter. Gryphon Financial Partners LLC grew its stake in UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after buying an additional 2,782 shares during the last quarter. Finally, TimesSquare Capital Management LLC bought a new position in UnitedHealth Group during the 4th quarter worth $500,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.4 %

Shares of NYSE UNH opened at $595.50 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company has a market cap of $549.90 billion, a price-to-earnings ratio of 36.40, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The business has a fifty day simple moving average of $557.22 and a 200-day simple moving average of $514.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the business earned $6.14 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.67 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.41%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on UNH. Barclays increased their price target on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. HSBC increased their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Truist Financial increased their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Wells Fargo & Company raised their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, UBS Group raised their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $614.17.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.